• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    System and method for the treatment with ultrasound of fractures, osteo-musculoskeletal injuries, postoperative pain and osteonecrosis in the field of medicine and veterinary medicine and their uses. It consists of an electronic system for the controlled and autonomous treatment of fractures, osteo-musculoskeletal injuries, postoperative pain, and osteonecrosis composed of portable ultrasound generator, electronic prescription, centralized platform of web services and computer application for the ultrasound treatment in the health field or outside it, both in medicine and in veterinary medicine. The method controls the applied treatment, it is charged by the healthcare staff in an electronic prescription so that it can be administered by the patient or non-health personnel autonomously, being controlled through a computer application and a web platform used to activate the therapy team, write and delete the electronic prescription, transfer the data stored in the therapy equipment to the web services platform to analyze the quantity and quality of the treatments, and update the program. A portable generator of pulsatile ultrasounds with defined parameters that can not be modified for the treatment of thoracic, costal and sternal fractures, and post-surgical thoracic pain. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2636822A1
    申请号:ES201600168
    申请日:2016-03-03
    公开日:2017-10-09
    发明作者:Norberto SANTANA RODRIGUEZ
    申请人:Norcri Invest S L；Norcri Invest SL；
    IPC主号:
    专利说明:


    SYSTEM AND METHOD FOR TREATMENT WITH ULTRASOUND FRACTURES, OSTEO-MUSCLE-TENDLNOSES INJURIES, POST-SURGICAL PAIN and OSTEONECROSIS IN THE FIELD OF MEDICINE AND VETERINARY, AND ITS USES.
    The ultrasound of continuous or pulsatile form is used in the clinical activity for the treatment of the bone fractures of the extremities, the delay in the consolidation of the same and the muscular and tendon injuries.
    The present invention refers to an electronic system for the controlled and autonomous treatment in general of fractures, osteo-musculoskeletal lesions, post-surgical pain and osteonecrosis, comprising: a portable ultrasound generator, bl an electronic prescription ; cl a centralized web services platform; and dl a computer application. With this system, ultrasound treatment in the health sector or outside it, is carried out through a simple, reliable, safe and controllable methodology that minimizes the probability of human failure and offers multiple advantages to both patients and healthcare personnel in the field of medicine and veterinary medicine.
    The system makes the control of the treatment applied to the patient independent of the electronic equipment that supplies it, loads the treatment prescribed by the health personnel in an electronic prescription so that it can be administered by the patient or non-health personnel autonomously, without possibility of error, in a comfortable and safe way, being controlled through a computer application and a web platform used to activate the therapy equipment, write and delete the electronic prescription, transfer the data stored in the therapy equipment to analyze the amount and quality of treatments, and update the program of the treatment team.
    On the other hand, more specifically, the present invention also refers to a portable pulsed ultrasound generator with defined parameters that cannot be modified for the treatment of thoracic, costal and steric fractures, and post-surgical chest pain based on the same electronic system described . FIELD OF THE INVENTION
    The present invention falls within the industry of physical methods of therapeutic use based on a system and an electronic method for the application of ultrasound to enhance home therapy through a portable, simple, reliable, safe, low-cost and Controllable through a computer application and a web application platform in the field of medicine and veterinary medicine for the treatment of fractures and osteo-musculoskeletal lesions, post-surgical pain and osteonecrosis. BACKGROUND OF THE INVENTION
    Ultrasounds are used for the treatment of limb fractures and complications arising from their delay in consolidation (pseudoartoris); as well as in muscle-tendon pathology. Ultrasound treatments are usually performed in health centers, requiring frequent patient displacement, which causes compliance problems; as well as the need for a health operator to schedule each session and administer the treatment.
    U.S. Patent No. 4530360 from Duarte describes a non-invasive therapeutic methodology and an apparatus to apply ultrasound pulses to the skin in an area close to the bone lesion, being necessary for the healthcare professional to adjust the controls of frequency, work cycle, power and choose the size of the applicator and position of the applicator on the patient's skin. In addition to this, to apply the treatment, it is necessary for an operator to hold the applicator at the chosen application site for the duration of the treatment, immobilizing the patient and an operator.
    U.S. patents No. 5003965, 5186162 and 5211160 by Talish and Lifshey describe an ultrasound system where the transducer together with a small battery and the RF generator are located in a small applicator module that can be attached to the patient's body. In addition, it increases patient safety in the event that short circuits occur in the connector of the applicator module, making an optical -and not electrical-signal coupling between the central unit and the applicator module. The objective was to create a portable and ergonomic ultrasound therapy system that allows patient mobility while receiving their treatment.
    On the other hand, Talish et al. They show in US 6261249, that ultrasonic equipment adapted for home use responds to a configuration that can be arbitrarily established by any person who has the equipment, without these treatments being somehow controlled and monitored by staff sanitary. In said patent, Talish et al. They highlight a series of characteristics that the team must control as they are: the flexibility in the start time of the daily sessions provided that a maximum of 2 sessions is fulfilled for each period of 36 hours, the possibility of interrupting the treatment momentarily, detecting and inform the user of the lack of gel between the transducer and the skin, the ability to measure and correct the level of power delivered to the patient, and the creation of a historical record of the treatment that the patient has carried out over time .
    The team proposed by Talish et al. It is automatically deactivated once the patient has received his therapy. To re-enable it, health personnel must access
    by means of a secret code or an intelligent battery to be able to program a new treatment in the equipment. OBJECT OF THE INVENTION
    Establish an electronic, safe and reliable system for the autonomous treatment with ultrasound through digital electronic prescription, controlled by means of a centralized web platform and a computer application, that makes the control of the therapy applied to the patient independent of the electronic equipment that supplies the treatment, contributing a new methodology to the field of ultrasonic treatment that is also verifiable and controllable and that minimizes the probability of human error.
    Design a portable, universal, simple, easy-to-use, safe and reliable ultrasonic generating equipment capable of providing different dose parameters and treatment duration applicable to different types of pathologies such as: fractures in general and delays in the consolidation of same, musculoskeletal lesions, post-surgical pain and osteonecrosis, so that it can be used in the health sector or outside it in the field of Medicine and Veterinary Medicine, by the patient himself or by non-health personnel without requiring of an intermediate health operator who schedules and administers the treatment.
    Allow the patient to administer the treatment at home without the possibility of error in the doses and times of treatment, and allow the healthcare staff to analyze the development of the therapy and the quantity and quality of the sessions, once the treatment has concluded.
    Based on the above objectives, design a pulsatile ultrasonic generator with specific parameters of dose and duration of treatment, not modifiable, with which to expand the field of therapeutic action of ultrasound to thoracic, costal and steric fractures for which there is no At present, a specific treatment, as well as for thoracic post-surgical pain, in the field of Medicine and Veterinary Medicine. DESCRIPTION OF THE INVENTION
    The ultrasonic treatment system of the present invention consists of a centralized web service platform (PSW), a computer application (APP), a set of programmable electronic recipes (REPl, at least one digital patient file (DE) and a portable ultrasound equipment for treatment (ETU).
    The Web Services Platform (PSW) provides a set of services aimed at healthcare personnel, said services being available at all times through the internet. Said health personnel can introduce electronic treatments (DEs) into the PSW, share said DEs and their experiences with other professionals, assign treatments to their patients, verify the application of the assigned treatments, record the results obtained and the incidents found.
    The PSW consists of a load balancer that distributes service requests between one or more servers and a single database. The servers communicate internally with the database through a local area network that is not accessible from outside.
    The REP or set of programmable electronic recipes is a physical device with sufficient capacity to store the DE, the REP being a cheap, lightweight, transportable, and time-resistant digital medium. By way of example, but not limiting the scope of the invention, the following supports are cited: cards with NFC technology, USB storage devices, memory cards and QR codes printed on surfaces, among others.
    The ED is a digital file that includes patient identification data, its diagnosis, all the technical characteristics of the assigned treatment, and a digital signature that guarantees that the previous data has not been manipulated by unauthorized third parties.
    The internal structure of the ETU is shown in the block diagram of Figure 2, and consists of the following modules: power supply, battery, system controller, non-volatile memory, communications card, real-time clock, user interface , RF oscillator, pulse modulator, transducer amplifier, piezoelectric transducer that can be internal or external, and therapy monitor.
    The power supply is responsible for managing the energy of the ETU. Among its functions are: charging the battery; power digital systems; indicate to the system controller the battery charge level through the Charge signal; indicate to the system controller if the equipment is powered by a battery or if it is connected to the mains via the Battery signal; and put the system into low power consumption mode in response to the Standby command of the system controller.
    In low power mode, the power of the RF oscillator, pulse modulator, transducer amplifier, piezoelectric transducer and therapy monitor is cut, so that these modules are temporarily inoperative.
    The system controller is a digital system based on a commercial micro-controller and contains at least program memory, data memory, digital input and output ports, analog input and output ports (via AOC and OAC converters), a set of interruptions, and optionally a timer module. Its function is to control the different modules of the ETU by sequential execution of the control program that is stored inside.
    The real-time clock provides the system controller with a date and time reference. For this, it has its own power source so that its operation does not depend on the battery.
    The user interface, as a module responsible for interacting with the patient and communicates with the system controller through a bus for the user interface. The user interface may contain one or more of the following elements: a power button, a speaker, a touch screen.
    The RF oscillator consists of a variable frequency synthesizer that generates an Osc sinusoidal signal, whose frequency is the basis of the ultrasound, and depends on the digital code present at the Fosc input. Additionally, the RF oscillator generates a square signal of fixed frequency equal to 1 MHz; therefore, the time between rising edges of this signal is an exact time of l ~ s. Both signals enter the pulse modulator.
    The method for carrying out the treatment of the present invention is based on a program that can establish the following operating modes: ready mode (REAOY), therapy mode (RUN), pause therapy mode (PAUSE), data dump mode ( OUMP) and program update mode (FLASH), the READY, RUN and DUMP modes must be at least present, and the PAUSE and FLASH modes are optional.
    - In READY mode, the ETU shows the patient a summary of the status of the device through the user interface. The following information must be present in said summary: the date and time supplied by the relay in real time, the battery charge level; and if the battery is charging or not. During this mode, the system controller instructs the power supply to put the ETU into low power consumption mode through the Standby command. At all times, as long as the ETU detects that it is connected to the mains via the Battery signal, the system controller will remain in READY mode.
    If the communications card receives data, the system controller checks the authenticity and validity of the data by checking the digital signature. If the signature is correct then depending on the type of message it proceeds as follows: -If the message read is a valid DE, the system controller checks if the current date and time supplied by the real-time clock are within the established range in the ED, and if the time elapsed since the last therapy that the patient has received that is registered in the non-volatile memory, complies with the nEo specification, if so, the system controller will switch to RUN mode. If the message read is a memory dump request, the system controller will switch to DUMP mode. If the message read is a program update request, the system controller will go to FLASH mode.
    - In RUN mode, the ETU shows the user through the user interface, the remaining therapy time and instructions on how to position and fix the piezoelectric transducer in the body. Once the scheduled therapy time is over, the system controller will go into READY mode. During RUN mode, the patient has the option to pause therapy momentarily. If the patient interacts with the user interface in this regard, or if an alarm situation occurs, the system controller will switch to PAUSE mode. If during the RUN mode it is detected that the ETU is connected to the mains (Battery), an alarm situation is generated, so the system controller will go to PAUSE mode, other alarm situations being: battery level too low , detection by the therapy monitor of a short circuit in the piezoelectric transducer, or the detection of an open circuit in the piezoelectric transducer. During the RUN mode, the power transmitted to the patient in mW / cm2 is periodically calculated and recorded in the non-volatile memory, based on the data provided by the therapy monitor. An example of data that the therapy monitor must provide to the system controller is the size of the piezoelectric transducer (section in cm2). the mean quadratic value of the voltage in the piezoelectric transducer, and the mean quadratic value of the current flowing through the piezoelectric transducer. Once the level of power transmitted to the patient has been calculated and recorded, the system controller compares that level with that established in the nE and acts on the Gain gain factor of the transducer amplifier so that the power transmitted to the patient corresponds to the power nominal treatment.
    - During PAUSE mode, the therapy time is stopped and the output power is deactivated by the Output_enable command that enters the transducer amplifier. The patient has the option to continue the therapy by interacting with the user interface. If there is no alarm situation and the patient requests to continue therapy, the system controller will switch to RUN mode.
    - In DUMP mode, all information recorded in nonvolatile memory related to therapy sessions carried out by the ETU is sent through the communications card. Once the data transfer is confirmed, the system controller deletes all data stored in non-volatile memory and enters RUN mode. In FLASH mode, the ETU receives a sequence of bytes through the communications card. This sequence is checked against transmission errors. If the check is correct, the system controller will erase all program memory of the microcontroller and record the new sequence of bytes received in that zone. Then, the system controller passes RUN mode and the microcontroller starts with the new program.
    The procedure for the implementation of the operation of the system is developed in the following stages:
    The pulse modulator receives from the system controller the ton activation time and the Toft deactivation time that set the duty cycle of the pulsing ultrasound signal; and receives from the RF oscillator the sine signal osc and the square signal. Said pulse modulator generates a modulated signal mod_Out by cyclically repeating the following actions in sequence: connecting the modulated signal mod_Out to the sinusoidal signal Ose; count ton cycles of the square signal; disconnect the modulated signal mod Out from the sinusoidal signal Ose; count Toft cycles of the square signal
    - The transducer amplifier receives the modulated signal mod_Out from the pulse modulator, amplifies it and converts it so that the ultrasound energy can be effectively applied to the patient through the piezoelectric transducer. During therapy, the Gain gain factor is continuously adjusted by the system controller. This continuous setting is recorded in nonvolatile memory. Said transducer amplifier receives from the system controller the Output_enable command that activates or deactivates the output power. In activated mode, the transducer amplifier connects the output power to the piezo transducer. Otherwise, the piezoelectric transducer is isolated without receiving any energy.
    - The function of the therapy monitor is to provide the system controller with a sufficient set of measures throughout the therapy that allow the system controller to adjust and calibrate the treatment; and monitor the existence of certain alert situations. As an example, some alert situations are the lack of gel on the patient's skin, the existence of a short circuit in the piezoelectric transducer connector, the disconnection of the piezoelectric transducer, or that the piezoelectric transducer is not in contact with the patient's skin . The therapy monitor should alert the system controller in case of any of these situations.
    - The specific implementation of the transducer amplifier and the therapy monitor depends on the type of piezoelectric transducer chosen, since each manufacturer works with different materials, electrode sizes, connectors and application methods. The methodology proposed by the present invention is not limited to a particular piezoelectric transducer.
    - The communications card is the subsystem responsible for the transfer of digital data abroad and can communicate through one or more of the following protocols: NFC (ISO 14443), WiFi (IEEE 802.11), Ethernet (IEEE 802.3), Bluetooth (IEEE 802.15), or U5B, allowing the ETU to both read the REPs and establish two-way communication with any device running the APP and that has a compatible communications interface.
    - The ETU receives a valid and digitally signed TIE through the communications module to activate. This TIE acts as a personalized digital key that the patient needs for each treatment session. The TIE can be read from a REP or transmitted directly from any device that runs the APP and has a communications protocol compatible with the ETU. Once the ETU is activated, the therapy session is carried out with the maximum guarantees of safety and reliability for the patient. Additionally, the ETU acquires and stores certain data of interest during the therapy sessions, these being subsequently transferred to the P5W through the APP.
    - To carry out the treatment, the ETU needs a piezoelectric transducer that must be fixed on the patient's skin, which transducer can be included in the ETU, or connected externally by means of a cable and a connector.
    - To receive each treatment session, the patient activates the ETU first and then follows the instructions shown on the screen, being able to carry out the ETU activation by reading a REP, or directly by digitally transferring the data of the TIE through the APP. The patient is responsible for recharging the ETU to avoid running out of battery during the treatment and during the application of the treatment, the ETU displays the time remaining for the end of the session and continuously adjusts the power level, the oscillation frequency and the type of modulation according to the information contained in the TIE. The ETU continuously monitors a set of securities, such as the battery level, the presence of gel between the transducer and the patient, the presence of short circuits in the transducer connector, or the disconnection of the transducer by the patient. Both the ultrasound power delivered to the patient and the incidents that may occur during treatment are recorded in the ETU.
    - Health personnel acquire the right to use the PSW through an identity verification system. In said service platform, health personnel, among other services, may: 1) authorize third parties to use the APP to perform maintenance operations on the ETUs and on the REPs; 2) register patients and establish their diagnoses; assign electronic treatments (TTEs) to their patients; 3) configure the technical characteristics of the TTEs associated with each diagnosis; 4) review the data collected in the ETU during patient therapy sessions; 5) assess the effectiveness of the treatment assigned to each patient; 6) Share the TTEs you want and your ratings with other professionals; 7) establish dialogues and consultations with other professional users of the PSW.
    - Maintenance operations are carried out through the APP, which is available for different platforms, the functions of the APP being the following: 1) schedule a REP with the TTE assigned to a patient so that he can comfortably perform it at home; 2) erase a REP completely; 3) activate a HU with the TTE assigned to a patient; 4) dump the data recorded in the HUs during the different therapy sessions on the PSW; and 5) update the ETU program version. So patients receive a HU and a personalized REP for their treatment.
    - On the other hand, those patients who have an ETU at home and who have been previously diagnosed, have the option of acquiring a new REP in a treatment center, or they can use the APP to acquire a TTE appropriate to their condition, from anywhere and at any time under the supervision of the optional staff.
    - Once the treatment is finished, the medical staff may use the APP to dump the information registered in the ETU about the PSW and delete the information stored in both the HU and the REP for a new use. Health workers may use the APP to update the ETU program version.
    From that moment, the medical staff will be able to access the PSW to examine and validate the application of the treatment and assess its effectiveness in the patient.
    The present invention can be applied to different uses, among which are the following:
    - Use of the system and method for the ultrasonic treatment of fractures in general and their consolidation delays.
    - For the ultrasonic treatment of limb fractures and their consolidation delays.
    - For the ultrasound treatment of osteo-muscular and tendon lesions.
    - For the ultrasonic treatment of acute or chronic post-surgical pain.
    5 -For the treatment of osteonecrosis lesions
    - For the ultrasonic treatment of thoracic, rib and steric fractures and their consolidation delays
    - For the treatment of costal and steric fractures and their consolidation delays and in the treatment of post-surgical chest pain with a
    10 portable generator that emits a non-modifiable dose of pulsating ultrasound of 1Mhz frequency, intensity of 0.5W / cm2, applied to 10% using pulses of 1ms every 9 ms (50mw / cm2) with a duration of 1 min / cm2 of area to be treated
    BRIEF DESCRIPTION OF THE DRAWINGS
    15 For a better understanding of the invention, some descriptive drawings are attached to this specification, in which: - Figure 1: Shows the structure of the web services platform, PSW. -Figure 2: Shows the block diagram of the ultrasonic therapy equipment, ETU. The numerical references of the figures correspond to the following constituent elements 20 of the invention:
    one. Load balancer
    2. Servers
    3. Database
    Four. Local area network
    25 5. Power supply
    6. Drums
    7. System controller
    8. Non volatile memory
    9. Communications card
    10. Real time clock
    5 11. User interface
    12. On button
    13. Speaker
    14. Touch screen
    fifteen. RF oscillator 10 16. Pulse modulator
    17. Transducer amplifier
    18. Piezo transducer
    19. Therapy monitor
    twenty. Signal Charge 15 21. Signal Battery
    22 Standby
    2. 3. Date and time reference
    24. Bus for user interface
    25. Fosc 20 input 26. Square signal
    27. Sine signal Osc
    28. Ton activation time
    29. Toff deactivation time
    30. Modulated signal mod Out
    s 31. Fain gain factor
    32. Order Output_enable
    DESCRIPTION OF A PREFERRED EMBODIMENT
    10 A preferred embodiment of the present invention may consist of an ultrasonic treatment system comprising a centralized web service platform (PSW), a computer application (APP), a portable ultrasonic treatment equipment (ETU), a set of Programmable electronic recipes (REP) and at least one electronic processing file (DE)
    15 20 The PSW consists of a load balancer (1) that distributes service requests between one or more servers (2) communicated internally with a single database (3) through a local area network (4) not accessible from the Exterior. Through an identity verification system, authorized users can enjoy permanent services from the Internet offered by the PSW: a) authorize third parties to use the APP to perform maintenance operations on the ETUs and on the REPs; b) register patients, establish diagnoses and assign electronic treatments (EDs); c) configure the technical characteristics of the DEs associated with each diagnosis; d) review the data collected in the ETU during therapy sessions; e) assess the effectiveness of the assigned treatment; f) share DEs and their ratings with other users; g) establish dialogues and consultations with other users.
    25 The ED is a digital file that includes patient identification data, its diagnosis, the technical characteristics of the assigned treatment, and a digital signature that guarantees that such data has not been manipulated by unauthorized third parties.
    30 The REP is a physical device capable of storing at least one DE, such as: cards with NFC technology, storage devices used, memory cards and printed QR codes, among others
    The APP is a computer application available for different platforms that performs a series of functions: a) program a REP with the TTE assigned to a patient; b) erase a REP and / or the data stored in an ETU completely; c) activate an ETU with the assigned TTE; d) dump in the PSW the data registered in the ETUs during the different sessions; and e) update the ETU program version.
    The ETU comprises the following modules: power supply (5), battery (6), system controller (7), non-volatile memory (8), communications card (9), real-time clock (10), interface user (11), RF oscillator (15), pulse modulator (16), transducer amplifier (17), internal or external piezoelectric transducer (18), and therapy monitor (19). The communications card (9) is the module responsible for both reading the REPs and establishing two-way communication with any device that runs the APP and has a compatible communications interface. As a subsystem responsible for the transfer of digital data abroad, it can communicate through one or more of the following protocols: NFC (ISO 14443), WiFi (IEEE 802.11), Ethernet (IEEE 802.3), Bluetooth (IEEE 802.15), or USB
    In a different embodiment of the present invention, for the specific treatment of costal and steric fractures, their consolidation delays and post-surgical chest pain, the ETU emits a non-modifiable dose of pulsating ultrasound of 1Mhz frequency, 0.5W / cm2, 50mw / cm2 and 1 min / cm2 duration.
    The method for carrying out the treatment of the present invention is based on a program that can establish the following modes of operation of the ETU: prepared mode (READY), therapy mode (RUN), pause therapy mode (PAUSE), dump mode data (DUMP) and program update mode (FLASH). At least, the READY, RUN and DUMP modes must be present, with the PAUSE and FLASH modes being optional.
    - In READY mode, the ETU is in low power consumption mode, the power being cut to the RF oscillator (15), the pulse modulator (16), the transducer amplifier (17), the piezoelectric transducer (18) and the therapy monitor (19), these modules being temporarily inoperative. The ETU shows a summary of the status of the device through the user interface (11), specifically the date and time, the battery charge level (6) and whether or not it is charging. When the communications card (9) receives data (either from a REP or transmitted from any device that runs the APP and has a compatible communications protocol), the system controller (7) checks its authenticity and validity. If it is a valid TTE, the current date and time and the time elapsed since the last therapy provided are within the range established in the TTE, the ETU will enter RUN mode. On the other hand, if the message read is a memory dump request it will go to DUMP mode and if it is a program update request it will go to FLASH mode.
    In RUN mode, the ETU shows the user through the user interface (11). the remaining therapy time and instructions on how to position and fix the piezoelectric transducer in the body (18). During this mode, the ETU supplies the assigned treatment and periodically calculates and records in its non-volatile memory
    (8) the power transmitted to the patient in mW / cm2 and compares said level with that established in the DE, acting on the Gain gain factor (31) of the transducer amplifier (17) so that the power transmitted to the patient corresponds to the nominal power of treatment Once the programmed time is over, the ETU returns to READY mode. At any time during treatment, the patient has the option of momentarily pausing therapy and if this occurs,
    or if an alarm situation occurs, the ETU goes into PAUSE mode. Alarm situations include: detection of the ETU being connected to the mains, a battery level that is too low, or detection of short circuits or open circuits in the piezoelectric transducer (18). Both the ultrasound power delivered to the patient and the incidents that may occur during treatment are recorded in the non-volatile memory (8) of the ETU.
    - During PAUSE mode, the therapy time is stopped and the output power entering the transducer amplifier (17) is deactivated. If there is no alarm situation and the patient requests to continue the therapy through the user interface (11). the ETU returns to RUN mode.
    - In DUMP mode, all the information registered in the non-volatile memory (8) is sent through the communications card (9). Once the data transfer is confirmed, the system controller (7) deletes all data stored in the non-volatile memory (8) and the ETU enters RUN mode.
    - In FLASH mode, the ETU receives a sequence of bytes through the communications card (9) and verifies that the transmission has been correct. If so, the system controller (7) erases all the program memory of the microcontroller and records the new sequence of bytes received in it. Then, the system controller (7) goes into RUN mode and the microcontroller is started with the new program.
    The present invention can be applied to different uses, among which are the following:
    - Use of the system and method for the treatment of fractures in general and their consolidation delays.
    - For the treatment of limb fractures and their consolidation delays.
    5 -For the treatment of osteo-muscular and tendon lesions.
    - For the treatment of acute or chronic post-surgical pain.
    - For the treatment of osteonecrosis
    - For the treatment of thoracic, rib and steric fractures and their consolidation delays
    10 -For the treatment of costal and steric fractures and their consolidation delays and in the treatment of post-surgical thoracic pain with a portable generator that emits a non-modifiable dose of pulsating ultrasound of 1Mhz frequency, intensity of 0, SW / cm2, applied to 10% using pulses of 1ms every 9 ms (SOmw / cm2) with a duration of 1 min / cm2 of area to be treated.
    权利要求:
    Claims (7)
    [1]
    1.-System for the treatment with ultrasound of fractures, osteo-musculotendinous lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine, characterized by comprising: A centralized web services platform (PSW), a computer application (APP ), a portable ultrasonic equipment for treatment (ETU), a set of programmable electronic recipes (REP) and at least one electronic treatment file (TTE), said PSW being constituted by a load balancer (1) that distributes the service requests between one or more servers (2) communicated internally with a single database (3) through a local area network (4) not accessible from outside.
    [2]
    2.-System for the treatment with ultrasound of fractures, osteo-musculotendinous lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine, according to the first claim, characterized in that said TTE is a digital file that includes identifying data of the patient, its diagnosis, the technical characteristics of the assigned treatment, and a digital signature that guarantees that said data has not been manipulated by unauthorized third parties.
    [3]
    3.-System for the treatment with ultrasound of fractures, osteo-musculotendinous lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine, according to claims 1 and 2, characterized in that said REP is a physical device with storage capacity at least one TTE, such as: cards with NFC technology, USB storage devices, memory cards and printed QR codes, among others
    [4]
    4.-System for the treatment with ultrasound of fractures, osteo-musculotendinous lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine, according to claims 1 to 3, characterized in that said APP is a computer application available for different platforms which performs a series of functions: a) program a REP with the TTE assigned to a patient; b) erase a REP and / or the data stored in an ETU completely; c) activate an ETU with the assigned TTE; d) dump in the PSW the data registered in the ETUs during the different sessions; and e) update the ETU program version.
    [5]
    5.-System for the treatment with ultrasound of fractures, osteo-musculotendinous lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine, according to claims 1 to 4, characterized in that said ETU comprises the following modules: power supply ( 5), battery (6), system controller (7), non-volatile memory (8), communications card (9), real-time relay (10), user interface (11), RF oscillator (15) , pulse modulator (16), transducer amplifier (17), internal or external piezoelectric transducer (18), and therapy monitor (19).
    [6]
    6.-Method to carry out the treatment of the previously claimed system, characterized by being developed in the following stages:
    In a first stage, in READY mode, in which the ETU is in low power consumption mode, the power to the RF oscillator (15), the pulse modulator (16), the transducer amplifier (17) is cut off. ), the piezoelectric transducer (18) and the therapy monitor (19), these modules being temporarily inoperative, such that when the communications card (9) receives data, either from a REP or transmitted from any device that executes The APP and has a compatible communications protocol, the system controller (7) checks its authenticity and validity and if it is a valid DE, the current date and time and if the time elapsed since the last therapy provided is within the established range in the DE, the ETU will go to RUN mode, while if the message read is a memory dump request it will go to DUMP mode and if it is a program update request it will go to FLASH mode.
    In a second stage, in RUN mode, in which the ETU supplies the assigned treatment and periodically calculates and records in its non-volatile memory (8) the power transmitted to the patient in mW / cm2 and compares that level with that established in the DE , acting on the Gain gain factor (31) of the transducer amplifier (17) so that the power transmitted to the patient corresponds to the nominal power of the treatment, and after the programmed time has elapsed, the ETU returns to READY mode, (taking into At any time during the treatment, the patient has the option to pause the therapy momentarily and if this occurs, or if an alarm situation occurs), passing the ETU goes into PAUSE mode, in alarm / detection situations that the ETU is connected to the mains, a battery level that is too low, or detection of short circuits or open circuits in the piezoelectric transducer (18), and the power of the ETU is recorded in the nonvolatile memory (8) of the ETU Ultrasound delivered to the patient as the incidents that may occur during treatment.
    During PAUSE mode, in which the therapy time is stopped and the output power entering the transducer amplifier (17) is deactivated, if there is no alarm situation, the ETU returns to RUN mode.
    In a third stage. In DUMP mode, all the information registered in the non-volatile memory (8) is sent through the communications card (9) and once the data transfer is confirmed, the system controller (7) deletes all the data stored in non-volatile memory (8) and the ETU goes to
    5 RUN mode.
    In a fourth stage, in FLASH mode, the ETU receives a sequence of bytes through the communications card (9) and verifies that the transmission has been correct. If so, the system controller (7) deletes all program memory from the microcontroller and saves the new byte sequence to it.
    10 received Then, the system controller (7) goes into RUN mode and the microcontroller is started with the new program.
    [7]
    7.-Use of the previously claimed system, for the treatment of costal and steric fractures and their consolidation delays and in the treatment of post-surgical chest pain with a portable generator that emits a non-modifiable dose of ultrasound
    15 pulsatile of 1Mhz frequency, intensity of O, 5W / cm2, applied to 10% using pulses of 1ms every 9 ms (50mw / cm2) with a duration of 1 min / cm2 of area to be treated.
    1 4
     ~ _. -..._ --------------------------------- _ .. --------. _quot;
    ~ ~
    . ,
    /
    '------------------------------------------------- ---_.2. 3
    FIG 1
    22 21 23 24 25
    AC
    12 13 14
     / 19
    28 29 30 31 32
    FIG 2
    类似技术:
    公开号 | 公开日 | 专利标题
    US8532764B2|2013-09-10|Post-download patient data protection in a medical device
    US10298072B2|2019-05-21|System and method for wireless AED docking
    US9082273B2|2015-07-14|Stimulation apparatus
    US6840955B2|2005-01-11|Therapeutic apparatus
    AU2020203861B2|2021-09-23|Apparatus and method for providing hyperthermia therapy
    ES2744701T3|2020-02-26|Modular stimulation application system
    ES2746915T3|2020-03-09|Medical device
    US8666488B2|2014-03-04|Post-download patient data protection in a medical device
    AU6972598A|1998-11-13|Apparatus for ultrasonic bone treatment
    US9161692B2|2015-10-20|Wireless monitoring apparatus used in conjunction with an automated external defibrillator | system for multiple patient rescue during mass casualty incidents
    CA2839532A1|2012-12-20|Percutaneous tibial nerve stimulator
    ES2636822B1|2018-06-07|System and method for the ultrasonic treatment of fractures, osteo-musculoskeletal lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine and their uses
    CN111787889A|2020-10-16|Hot and/or cold pad
    US20170216617A1|2017-08-03|Portable, Pre-calibrated and Wearable Laser Device for Treating Pain and Inflammation
    US20210038907A1|2021-02-11|Systems and methods for enabling point of care magnetic stimulation therapy
    US20160117452A1|2016-04-28|Systems and methods for prescriptions for noninvasive electrical brain stimulation
    同族专利:
    公开号 | 公开日
    WO2017149173A4|2017-11-02|
    CN108778422B|2021-03-05|
    WO2017149173A1|2017-09-08|
    US20200289854A1|2020-09-17|
    CN108778422A|2018-11-09|
    EP3424563A4|2019-04-03|
    EP3424563A1|2019-01-09|
    ES2636822B1|2018-06-07|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    AT283095T|1997-04-18|2004-12-15|Exogen Inc|DEVICE FOR ULTRASONIC BONE TREATMENT|
    US7426475B1|2000-03-21|2008-09-16|Mahesh Tangellapally|Secure electronic healthcare information management process and system|
    CN2628082Y|2003-04-16|2004-07-28|王芷龙|Portable ultrasound health care instrument|
    JP2006268186A|2005-03-22|2006-10-05|Toshiba Social Automation Systems Co Ltd|Electronic prescription system|
    US20080155077A1|2006-12-20|2008-06-26|James Terry L|Activity Monitor for Collecting, Converting, Displaying, and Communicating Data|
    CN101306228A|2007-05-18|2008-11-19|才秀君|Electromagnetic field and ultrasonic wave composite therapy device for osteoporosis|
    US20090254008A1|2008-01-29|2009-10-08|Shields Jr Donald J|Systems, devices, and methods to concurrently deliver ultrasound waves having thermal and non-thermal effects|
    US20100063834A1|2008-09-09|2010-03-11|Santosh Mukherjee|Medical Communication System|
    CN101362005A|2008-09-11|2009-02-11|高春平|Intelligent ultrasonics therapy method and device|
    WO2011133628A1|2010-04-21|2011-10-27|Raymond Koverzin|Remotely managed assistive device|
    EP2627277B1|2010-10-12|2019-11-20|Smith & Nephew, Inc.|Medical device|
    US10755368B2|2012-03-26|2020-08-25|Tc1 Llc|Medical equipment customer web portal|
    US10089443B2|2012-05-15|2018-10-02|Baxter International Inc.|Home medical device systems and methods for therapy prescription and tracking, servicing and inventory|
    US20150213204A1|2013-11-05|2015-07-30|MS Card Central Corp.|Dual smart card e-prescription system and method|CN111632283A|2020-04-27|2020-09-08|深圳市普罗医学股份有限公司|Ultrasonic treatment equipment for chest and lung treatment|
    法律状态:
    2018-06-07| FG2A| Definitive protection|Ref document number: 2636822 Country of ref document: ES Kind code of ref document: B1 Effective date: 20180607 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES201600168A|ES2636822B1|2016-03-03|2016-03-03|System and method for the ultrasonic treatment of fractures, osteo-musculoskeletal lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine and their uses|ES201600168A| ES2636822B1|2016-03-03|2016-03-03|System and method for the ultrasonic treatment of fractures, osteo-musculoskeletal lesions, post-surgical pain and osteonecrosis in the field of medicine and veterinary medicine and their uses|
    PCT/ES2017/000021| WO2017149173A1|2016-03-03|2017-03-01|System and method for the ultrasonic treatment of fractures, bone, muscle and tendon injuries, post-surgery pain and osteonecrosis in human and veterinary medicine, and uses thereof|
    CN201780018320.1A| CN108778422B|2016-03-03|2017-03-01|System for ultrasound treatment in the medical and veterinary fields|
    EP17759306.8A| EP3424563A4|2016-03-03|2017-03-01|System and method for the ultrasonic treatment of fractures, bone, muscle and tendon injuries, post-surgery pain and osteonecrosis in human and veterinary medicine, and uses thereof|
    US16/081,950| US20200289854A1|2016-03-03|2017-09-08|System and method for the ultrasonic treatment of fractures, bone, muscle and tendon injuries, post-surgery pain and osteonecrosis in human and veterinary medicine, and uses thereof|
    [返回顶部]